Z-PHE-ALA-OH
Z-PHE-ALA-OH Basic information
- Product Name:
- Z-PHE-ALA-OH
- Synonyms:
-
- CBZ-L-PHE-ALA
- CBZ-L-PHE-L-ALA
- Z-PHE-ALA-OH
- Z-PHE-ALA
- Z-L-PHENYLALANYL-L-ALANINE
- N-CBZ-PHE-ALA
- N-CARBOBENZOXY-L-PHENYLALANYL-L-ALANINE
- N-BENZYLOXYCARBONYL-L-PHENYLALANYL-L-ALANINE
- CAS:
- 21881-18-5
- MF:
- C20H22N2O5
- MW:
- 370.4
- Product Categories:
-
- Amino Acid Derivatives
- Mol File:
- 21881-18-5.mol
Z-PHE-ALA-OH Chemical Properties
- Melting point:
- 151-154 °C
- storage temp.
- Sealed in dry,2-8°C
- solubility
- methanol: ~50mg/mL, almost clear, almost colorless
- Boiling point:
- 666.1±55.0 °C(Predicted)
- Density
- 1.253±0.06 g/cm3(Predicted)
- pka
- 3.50±0.10(Predicted)
- form
- powder
Safety Information
- Safety Statements
- 22-24/25
Z-PHE-ALA-OH Usage And Synthesis
Chemical Properties
White to off-white powder
Uses
Sensitive substrate for cathepsin A.
Synthesis
3397-32-8
56-41-7
3338-39-4
The general procedure for the synthesis of the compound (CAS:3338-39-4) from (S)-2,5-dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-3-phenylpropanoate and L-alanine was as follows: with reference to the method of Itoh [M. Itoh, Chem. Pharm. Bull., 20, 664 (1972)], to L- alanine (18 mmol, 1.60 g) dissolved in 200 mL of a 1:1 dioxane-water mixture to triethylamine (36 mmol, 5.0 mL). Solid carbon dioxide tablets were added under stirring conditions until the solution pH reached 8. Subsequently, N-Benzyloxycarbonyl-L-phenylalanine N-hydroxysuccinimide ester (18 mmol, 7.13 g) was added under stirring at room temperature. After 16-20 hours of reaction, the reaction mixture was acidified by slow addition of 1N HCl followed by extraction with ethyl acetate. The organic phase was separated, washed sequentially with water (twice) and brine, dried over MgSO4, concentrated by rotary evaporation and dried under high vacuum to give 6.19 g (93% yield) of N-Benzyloxycarbonyl-L-phenylalanyl-L-alanine as a white solid with a melting point of 160-164 °C (literature value: 165 °C; G.R. Pettit, 'Synthetic Peptides', Vol. 1, p. 141 (1970)). Using similar methods, the following compounds of formula (2) can be prepared according to the procedure described in Preparation 1.
References
[1] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 17, p. 6230 - 6237
[2] Patent: US5055451, 1991, A
[3] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 3, p. 1071 - 1078
Z-PHE-ALA-OHSupplier
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 18270980682
- mlcheng@sunwaypharm.cn
- Tel
- 021-021-021-67601398-809-809-809 15221380277
- marketing_china@spectrumchemical.com